Rowland developed a screening tool for Visit-A-Bit to measure the program’s effectiveness and determine incoming senior adult eligibility.
Rowland developed a screening tool for Visit-A-Bit to measure the program’s effectiveness and determine incoming senior adult eligibility.
Rowland developed a screening tool for Visit-A-Bit to measure the program’s effectiveness and determine incoming senior adult eligibility.
Rowland developed a screening tool for Visit-A-Bit to measure the program’s effectiveness and determine incoming senior adult eligibility.
Okere, who works as a senior director at Nurix Therapeutics, has built a career in pharmacovigilance and drug safety.